drugset / Trial / NCT05561985
Expanded Access Use of Itacitinib to Treat a Single Patient With STAT1 Gain of Function (GOF) Disease
Summary
Expanded access use of Itacitinib to treat a single patient with aplastic anemia.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Itacitinib | Small molecule | — | — |
Indications
No indication recorded.